These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 34020530)

  • 1. µ-Crystallin: A thyroid hormone binding protein.
    Kinney CJ; Bloch RJ
    Endocr Regul; 2021 May; 55(2):89-102. PubMed ID: 34020530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRYM mutations cause deafness through thyroid hormone binding properties in the fibrocytes of the cochlea.
    Oshima A; Suzuki S; Takumi Y; Hashizume K; Abe S; Usami S
    J Med Genet; 2006 Jun; 43(6):e25. PubMed ID: 16740909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of mouse mu-crystallin complexed with NADPH and the T3 thyroid hormone.
    Borel F; Hachi I; Palencia A; Gaillard MC; Ferrer JL
    FEBS J; 2014 Mar; 281(6):1598-612. PubMed ID: 24467707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging role of T3-binding protein μ-crystallin (CRYM) in health and disease.
    Aksoy O; Hantusch B; Kenner L
    Trends Endocrinol Metab; 2022 Dec; 33(12):804-816. PubMed ID: 36344381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid and androgen receptor signaling are antagonized by μ-Crystallin in prostate cancer.
    Aksoy O; Pencik J; Hartenbach M; Moazzami AA; Schlederer M; Balber T; Varady A; Philippe C; Baltzer PA; Mazumder B; Whitchurch JB; Roberts CJ; Haitel A; Herac M; Susani M; Mitterhauser M; Marculescu R; Stangl-Kremser J; Hassler MR; Kramer G; Shariat SF; Turner SD; Tichy B; Oppelt J; Pospisilova S; Hartenbach S; Tangermann S; Egger G; Neubauer HA; Moriggl R; Culig Z; Greiner G; Hoermann G; Hacker M; Heery DM; Merkel O; Kenner L
    Int J Cancer; 2021 Feb; 148(3):731-747. PubMed ID: 33034050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. μ-Crystallin controls muscle function through thyroid hormone action.
    Seko D; Ogawa S; Li TS; Taimura A; Ono Y
    FASEB J; 2016 May; 30(5):1733-40. PubMed ID: 26718889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of mu-crystallin as an androgen-regulated gene in human prostate cancer.
    Malinowska K; Cavarretta IT; Susani M; Wrulich OA; Uberall F; Kenner L; Culig Z
    Prostate; 2009 Jul; 69(10):1109-18. PubMed ID: 19353593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. μ-Crystallin in Mouse Skeletal Muscle Promotes a Shift from Glycolytic toward Oxidative Metabolism.
    Kinney CJ; O'Neill A; Noland K; Huang W; Muriel J; Lukyanenko V; Kane MA; Ward CW; Collier AF; Roche JA; McLenithan JC; Reed PW; Bloch RJ
    Curr Res Physiol; 2021; 4():47-59. PubMed ID: 34746826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into Enzyme Catalysis and Thyroid Hormone Regulation of Cerebral Ketimine Reductase/μ-Crystallin Under Physiological Conditions.
    Hallen A; Cooper AJ; Jamie JF; Karuso P
    Neurochem Res; 2015 Jun; 40(6):1252-66. PubMed ID: 25931162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of μ-crystallin causes PPARγ activation and obesity in high-fat diet-fed mice.
    Ohkubo Y; Sekido T; Nishio SI; Sekido K; Kitahara J; Suzuki S; Komatsu M
    Biochem Biophys Res Commun; 2019 Jan; 508(3):914-920. PubMed ID: 30545633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammalian forebrain ketimine reductase identified as μ-crystallin; potential regulation by thyroid hormones.
    Hallen A; Cooper AJ; Jamie JF; Haynes PA; Willows RD
    J Neurochem; 2011 Aug; 118(3):379-87. PubMed ID: 21332720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter to the editor: μ-crystallin/CRYM functions as a ketimine-reducing enzyme and plays a role in thyroid hormone bioavailability due to strong inhibition/regulation by thyroid hormones.
    Hallen A; Cooper AJ
    J Clin Endocrinol Metab; 2015 Jan; 100(1):L15-6. PubMed ID: 25559540
    [No Abstract]   [Full Text] [Related]  

  • 13. Comprehensive Corticospinal Labeling with mu-crystallin Transgene Reveals Axon Regeneration after Spinal Cord Trauma in ngr1-/- Mice.
    Fink KL; Strittmatter SM; Cafferty WB
    J Neurosci; 2015 Nov; 35(46):15403-18. PubMed ID: 26586827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of CRYM as a candidate responsible for nonsyndromic deafness, through cDNA microarray analysis of human cochlear and vestibular tissues.
    Abe S; Katagiri T; Saito-Hisaminato A; Usami S; Inoue Y; Tsunoda T; Nakamura Y
    Am J Hum Genet; 2003 Jan; 72(1):73-82. PubMed ID: 12471561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. micro-Crystallin as an intracellular 3,5,3'-triiodothyronine holder in vivo.
    Suzuki S; Suzuki N; Mori J; Oshima A; Usami S; Hashizume K
    Mol Endocrinol; 2007 Apr; 21(4):885-94. PubMed ID: 17264173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipose tissue μ-crystallin is a thyroid hormone-binding protein associated with systemic insulin sensitivity.
    Serrano M; Moreno M; Ortega FJ; Xifra G; Ricart W; Moreno-Navarrete JM; Fernández-Real JM
    J Clin Endocrinol Metab; 2014 Nov; 99(11):E2259-68. PubMed ID: 25057873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystallin-gazing: unveiling enzymatic activity.
    Reed PW; Bloch RJ
    J Neurochem; 2011 Aug; 118(3):315-6. PubMed ID: 21418222
    [No Abstract]   [Full Text] [Related]  

  • 18. Loss of the thyroid hormone-binding protein Crym renders striatal neurons more vulnerable to mutant huntingtin in Huntington's disease.
    Francelle L; Galvan L; Gaillard MC; Guillermier M; Houitte D; Bonvento G; Petit F; Jan C; Dufour N; Hantraye P; Elalouf JM; De Chaldée M; Déglon N; Brouillet E
    Hum Mol Genet; 2015 Mar; 24(6):1563-73. PubMed ID: 25398949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketimine reductase/CRYM catalyzes reductive alkylamination of α-keto acids, confirming its function as an imine reductase.
    Hallen A; Cooper AJ; Smith JR; Jamie JF; Karuso P
    Amino Acids; 2015 Nov; 47(11):2457-61. PubMed ID: 26173510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytosolic T3-binding protein modulates dynamic alteration of T3-mediated gene expression in cells.
    Takeshige K; Sekido T; Kitahara J; Ohkubo Y; Hiwatashi D; Ishii H; Nishio S; Takeda T; Komatsu M; Suzuki S
    Endocr J; 2014; 61(6):561-70. PubMed ID: 24646676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.